FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in MBX Biosciences Inc. (NASDAQ:MBX) as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 8 to their Schedule 13G with the SEC on November 5, 2026, disclosing their beneficial ownership of common stock in Marvell Technology Inc. as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed an amended Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 6,239,237 shares of Odyssey Therapeutics Inc. common stock as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of approximately 6.0% of Oddity Tech Ltd's Class A Common Stock as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in Midera Food Processing Inc. as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Myers Industries Inc. as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 4, 2026, disclosing their beneficial ownership of Nokia Corp common stock as of September 30, 2026.
FMR LLC filed an amended beneficial ownership statement with the SEC on November 4, 2026, disclosing a 2.3% stake in On Holding AG Class A Common Stock as of September 30, 2026.
FMR LLC and Abigail P. Johnson filed Amendment No. 4 to Schedule 13G with the SEC on November 4, 2026, disclosing their beneficial ownership of common stock in Monolithic Power Systems Inc as of September 30, 2026.
FMR LLC filed Amendment No. 8 to its Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 13,307,662.71 shares of Okta Inc. Class A common stock as of September 30, 2026.